Position in ANNX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,307,440
+$1,046,890 QoQ
Shares Held
236,000
+74.8% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. ANNX ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in ANNX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,307,440 | 236,000 | Shares | Sole | 2026-05-07 | |
| 2025-03-31 | $260,550 | 135,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $692,550 | 135,000 | Shares | Sole | 2025-02-10 | |
| 2022-03-31 | $148,785 | 54,500 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $581,394 | 50,600 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $625,296 | 33,600 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $756,336 | 33,600 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $840,768 | 30,200 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $755,906 | 30,200 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||